House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Urology · EAU

Urinary tract infection

EAU
A
Source:EAU Guidelines on Urological Infections (Limited Update April 2024)IDSA Guideline on Uncomplicated UTI (2024)NICE NG109 Pyelonephritis (2024)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • Suspected sepsis (qSOFA ≥2, NEWS2 ≥5, hypotension, lactate >2) — sepsis pathway with IV antibiotic within 1 h, fluids, lactate, blood cultures[1]
  • Obstructed pyelonephritis with stone or anatomic abnormality — emergency urology, urgent decompression (ureteric stent / percutaneous nephrostomy)[1]
  • Complicated UTI in pregnancy, transplant recipient, or with indwelling urinary catheter — broader cover, longer duration; senior input[1]
  • Recurrent UTI (≥2 in 6 months or ≥3 in 12 months) — investigate underlying cause; antibiotic stewardship[1]

First-line treatment

Interventions

  • Distinguish uncomplicated cystitis from pyelonephritis and complicated UTI[1]
    Uncomplicated cystitis: short-course oral antibiotic. Pyelonephritis: 7–14 day course, oral or IV. Complicated UTI (CKD, transplant, anatomic abnormality, immunosuppression, men, pregnancy): broader cover and longer course
  • Antibiotic stewardship[1]
    Use narrow-spectrum agents per local resistance data; avoid fluoroquinolones for uncomplicated cystitis; reserve carbapenems for known ESBL or critical illness; review at 48 h with culture sensitivities
  • Asymptomatic bacteriuria — selective treatment[1]
    Treat in pregnancy, before urological intervention with mucosal trauma, after kidney transplant first 1 month. Do NOT treat in healthy non-pregnant women, men, elderly, diabetics, catheterised patients
  • Recurrent UTI prevention[1]
    Behavioural: hydration, post-coital voiding, no spermicide; topical vaginal estrogen postmenopausal; cranberry products (modest); methenamine hippurate; antimicrobial prophylaxis for refractory cases (continuous low-dose, post-coital, or self-start)

First-line drug therapy

DrugClassAdultPaediatricNotes
Nitrofurantoin (uncomplicated cystitis)[1]Furan antimicrobial100 mg PO BD × 5 days≥3 months: 5–7 mg/kg/dayFirst-line for uncomplicated cystitis; effective concentration only in urine; avoid eGFR <30 (insufficient excretion); pulmonary fibrosis with prolonged use; safe in pregnancy except at term
Fosfomycin (uncomplicated cystitis)[1]Phosphonic acid antimicrobial3 g PO single dose (sachet dissolved in water)—Single-dose convenience for uncomplicated cystitis; resistance increasing; useful in suspected ESBL pathogen
Co-trimoxazole (uncomplicated cystitis)[1]Sulfonamide + trimethoprim160/800 mg PO BD × 3 days8/40 mg/kg/day in 2 divided dosesUse only where local E. coli resistance <20%; avoid in pregnancy near term, G6PD, severe renal impairment
Co-amoxiclav (alternative cystitis)[1]Aminopenicillin + beta-lactamase inhibitor625 mg PO TDS × 5 days20–40 mg/kg/day amoxicillin componentUseful in penicillin-tolerant; rising resistance; check local antibiogram
Ceftriaxone (pyelonephritis or complicated UTI)[1]Third-generation cephalosporin1–2 g IV daily; switch to oral cefuroxime 500 mg BD or per culture × total 10–14 days50–80 mg/kg/day IVFirst-line for pyelonephritis or complicated UTI requiring IV; switch to oral by culture sensitivity at 48–72 h
Piperacillin-tazobactam or meropenem (severe complicated UTI)[1]Beta-lactam ± beta-lactamase inhibitor / carbapenemPiperacillin-tazobactam 4.5 g IV every 6–8 h; meropenem 1 g IV every 8 hPer local protocolSevere complicated UTI, sepsis, ESBL or AmpC concern; renal dose adjustment; reassess at 48 h with cultures
Vaginal estrogen (postmenopausal recurrent UTI)[1]Local estrogenEstradiol 25 µg pessary or 0.1 mg cream nightly × 2 weeks then 2× weekly—First-line non-antibiotic prevention in postmenopausal women; minimal systemic absorption; safe with most contraindications to systemic HRT
Nitrofurantoin (uncomplicated cystitis)[1]
Furan antimicrobial
Adult
100 mg PO BD × 5 days
Paediatric
≥3 months: 5–7 mg/kg/day
First-line for uncomplicated cystitis; effective concentration only in urine; avoid eGFR <30 (insufficient excretion); pulmonary fibrosis with prolonged use; safe in pregnancy except at term
Fosfomycin (uncomplicated cystitis)[1]
Phosphonic acid antimicrobial
Adult
3 g PO single dose (sachet dissolved in water)
Paediatric
—
Single-dose convenience for uncomplicated cystitis; resistance increasing; useful in suspected ESBL pathogen
Co-trimoxazole (uncomplicated cystitis)[1]
Sulfonamide + trimethoprim
Adult
160/800 mg PO BD × 3 days
Paediatric
8/40 mg/kg/day in 2 divided doses
Use only where local E. coli resistance <20%; avoid in pregnancy near term, G6PD, severe renal impairment
Co-amoxiclav (alternative cystitis)[1]
Aminopenicillin + beta-lactamase inhibitor
Adult
625 mg PO TDS × 5 days
Paediatric
20–40 mg/kg/day amoxicillin component
Useful in penicillin-tolerant; rising resistance; check local antibiogram
Ceftriaxone (pyelonephritis or complicated UTI)[1]
Third-generation cephalosporin
Adult
1–2 g IV daily; switch to oral cefuroxime 500 mg BD or per culture × total 10–14 days
Paediatric
50–80 mg/kg/day IV
First-line for pyelonephritis or complicated UTI requiring IV; switch to oral by culture sensitivity at 48–72 h
Piperacillin-tazobactam or meropenem (severe complicated UTI)[1]
Beta-lactam ± beta-lactamase inhibitor / carbapenem
Adult
Piperacillin-tazobactam 4.5 g IV every 6–8 h; meropenem 1 g IV every 8 h
Paediatric
Per local protocol
Severe complicated UTI, sepsis, ESBL or AmpC concern; renal dose adjustment; reassess at 48 h with cultures
Vaginal estrogen (postmenopausal recurrent UTI)[1]
Local estrogen
Adult
Estradiol 25 µg pessary or 0.1 mg cream nightly × 2 weeks then 2× weekly
Paediatric
—
First-line non-antibiotic prevention in postmenopausal women; minimal systemic absorption; safe with most contraindications to systemic HRT

Safety-net

  1. Drink plenty of water and complete your antibiotic course; symptoms should improve within 48 h — return if worsening, fever, vomiting, or back pain[1]
  2. If you develop high fever, severe back pain, or systemic features — same-day medical review (pyelonephritis or sepsis)[1]
  3. Frequent UTIs warrant investigation; do not just take repeat antibiotics — see your clinician for cause and prevention[1]

Referral criteria

  • Sepsis or pyelonephritis with deterioration despite IV antibiotic at 48–72 hSenior medical team and urology[1]
  • Obstructed pyelonephritis or renal abscessUrology for urgent decompression[1]
  • Recurrent UTI requiring underlying-cause workupUrology with imaging and cystoscopy[1]
  • Pregnancy with UTI / pyelonephritisJoint obstetric and infection review; pregnancy-safe antibiotic[1]

Clinical summary

Diagnosis and stewardship-focused antimicrobial management of uncomplicated and complicated UTI in adults.

References

  1. 1.EAU Guidelines on Urological Infections (Limited Update April 2024); IDSA Guideline on Uncomplicated UTI; NICE NG109 Pyelonephritis (2024)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References